AtriCure Statistics
Total Valuation
AtriCure has a market cap or net worth of $1.88 billion. The enterprise value is $1.83 billion.
Important Dates
The last earnings date was Wednesday, February 12, 2025, after market close.
| Earnings Date | Feb 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AtriCure has 48.88 million shares outstanding. The number of shares has increased by 1.42% in one year.
| Current Share Class | 48.88M |
| Shares Outstanding | 48.88M |
| Shares Change (YoY) | +1.42% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 3.17% |
| Owned by Institutions (%) | 96.57% |
| Float | 47.33M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.87 |
| Forward PS | 3.52 |
| PB Ratio | 4.07 |
| P/TBV Ratio | 11.06 |
| P/FCF Ratio | 2,518.78 |
| P/OCF Ratio | 153.76 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 2,456.77 |
Financial Position
The company has a current ratio of 3.65, with a Debt / Equity ratio of 0.17.
| Current Ratio | 3.65 |
| Quick Ratio | 2.49 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | 102.72 |
| Interest Coverage | -6.25 |
Financial Efficiency
Return on equity (ROE) is -9.64% and return on invested capital (ROIC) is -4.64%.
| Return on Equity (ROE) | -9.64% |
| Return on Assets (ROA) | -4.09% |
| Return on Invested Capital (ROIC) | -4.64% |
| Return on Capital Employed (ROCE) | -7.47% |
| Revenue Per Employee | $357,928 |
| Profits Per Employee | -$34,383 |
| Employee Count | 1,300 |
| Asset Turnover | 0.76 |
| Inventory Turnover | 1.64 |
Taxes
In the past 12 months, AtriCure has paid $1.02 million in taxes.
| Income Tax | 1.02M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.30% in the last 52 weeks. The beta is 1.46, so AtriCure's price volatility has been higher than the market average.
| Beta (5Y) | 1.46 |
| 52-Week Price Change | +16.30% |
| 50-Day Moving Average | 36.19 |
| 200-Day Moving Average | 28.93 |
| Relative Strength Index (RSI) | 47.41 |
| Average Volume (20 Days) | 554,658 |
Short Selling Information
The latest short interest is 1.17 million, so 2.40% of the outstanding shares have been sold short.
| Short Interest | 1.17M |
| Short Previous Month | 1.47M |
| Short % of Shares Out | 2.40% |
| Short % of Float | 2.48% |
| Short Ratio (days to cover) | 1.91 |
Income Statement
In the last 12 months, AtriCure had revenue of $465.31 million and -$44.70 million in losses. Loss per share was -$0.95.
| Revenue | 465.31M |
| Gross Profit | 347.52M |
| Operating Income | -40.01M |
| Pretax Income | -39.27M |
| Net Income | -44.70M |
| EBITDA | -21.28M |
| EBIT | -40.01M |
| Loss Per Share | -$0.95 |
Full Income StatementBalance Sheet
The company has $122.72 million in cash and $76.53 million in debt, giving a net cash position of $46.19 million or $0.95 per share.
| Cash & Cash Equivalents | 122.72M |
| Total Debt | 76.53M |
| Net Cash | 46.19M |
| Net Cash Per Share | $0.95 |
| Equity (Book Value) | 460.97M |
| Book Value Per Share | 9.43 |
| Working Capital | 194.40M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $12.20 million and capital expenditures -$11.46 million, giving a free cash flow of $745,000.
| Operating Cash Flow | 12.20M |
| Capital Expenditures | -11.46M |
| Free Cash Flow | 745,000 |
| FCF Per Share | $0.02 |
Full Cash Flow StatementMargins
Gross margin is 74.69%, with operating and profit margins of -8.60% and -9.61%.
| Gross Margin | 74.69% |
| Operating Margin | -8.60% |
| Pretax Margin | -9.39% |
| Profit Margin | -9.61% |
| EBITDA Margin | -4.57% |
| EBIT Margin | -8.60% |
| FCF Margin | 0.16% |
Dividends & Yields
AtriCure does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.42% |
| Shareholder Yield | -1.42% |
| Earnings Yield | -2.38% |
| FCF Yield | 0.04% |
Dividend DetailsAnalyst Forecast
The average price target for AtriCure is $49.50, which is 28.94% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $49.50 |
| Price Target Difference | 28.94% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 17.34% |
| EPS Growth Forecast (5Y) | -20.84% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AtriCure has an Altman Z-Score of 5.53 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.53 |
| Piotroski F-Score | 4 |